Clinical significance of aberrant methylation of prostaglandin E receptor 2 (PTGER2) in nonsmall cell lung cancer: association with prognosis, PTGER2 expression, and epidermal growth factor receptor mutation. (Q54522319)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Clinical significance of aberrant methylation of prostaglandin E receptor 2 (PTGER2) in nonsmall cell lung cancer: association with prognosis, PTGER2 expression, and epidermal growth factor receptor mutation. |
scientific article |
Statements
Clinical significance of aberrant methylation of prostaglandin E receptor 2 (PTGER2) in nonsmall cell lung cancer: association with prognosis, PTGER2 expression, and epidermal growth factor receptor mutation. (English)
Makoto Suzuki
Takahiro Nakajima
Rieko Kubo
Yasuo Sekine
Kiyoshi Shibuya
Kenzo Hiroshima
Yukio Nakatani
Takehiko Fujisawa
Ichiro Yoshino
Thoracic Surgery Group
1 September 2008
113
6
1396-1403
1 reference
1 reference
1 reference
1 reference